Topological descriptors in modeling the antimalarial activity of 4-(3′,5′-disubstituted anilino)quinolines

Journal of Chemical Information and Modeling

Volumn 46, Issue 1, 2006, Pages 93-102

  Gupta, Manish K ^a   Prabhakar, Yenamandra S ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; MALARIA CONTROL; MATHEMATICAL MODELS; REGRESSION ANALYSIS; TOPOLOGY;

ANTIMALARIAL ACTIVITY; COMBINATORIAL PROTOCOL IN MULTIPLE LINEAR REGRESSION (CP-MLR); DESCRIPTORS; QUINOLINES;

DRUG PRODUCTS;

ANTIMALARIAL AGENT; QUINOLINE DERIVATIVE;

ARTICLE; CHEMICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; COMBINATORIAL CHEMISTRY; STRUCTURE ACTIVITY RELATION;

ANTIMALARIALS; COMBINATORIAL CHEMISTRY TECHNIQUES; MODELS, CHEMICAL; MOLECULAR STRUCTURE; QUINOLINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33244488303     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci0501140     Document Type: Conference Paper

References (33)

1. ω-Oxides. J. Med. Chem. 1986, 29, 924-939 and previous reports of the series.
2. Koh, H. L.; Go, M. L.; Ngiam, T. L.; Mak, J. W. Conformational and Structural Features Determining in vitro Antimalarial Activity in some Indolo[3,2-c]quinolines, Anilinoquinolines and Tetrahydroindolo[3, 2-d]benzazepines. Eur. J. Med. Chem. 1994, 29, 107-113.
3. O'Neill, P. M.; Willock, D. J.; Hawley, S. R.; Bray, P. G.; Storr, R. C.; Ward, S. A.; Park, B. K. Synthesis, Antimalarial Activity, and Molecular Modeling of Tebuquine Analogues. J. Med. Chem. 1997, 40, 437-448.
4. De, D.; Krogstad, F. M.; Byers, L. D.; Krogstad, D. J. Structure-Activity Relationships for Antiplasmodial Activity among 7-Substituted 4-Aminoquinolines. J. Med. Chem. 1998, 41, 4918-4926.
5. Hawley, S. R.; Bray, P. G.; Mungthin, M.; Atkinson, J. D.; O'Neill, P. M.; Ward, S. A. Relationship between Antimalarial Drug Activity, Accumulation, and Inhibition of Heme Polymerization in Plasmodium falciparum In Vitro. Antimicrob. Agents Chemother. 1998, 42, 682-686.
6. O'Neill, P. M.; Bray, P. G.; Hawley, S. R.; Ward, S. A.; Park, B. K. Aminoquinolines-Past, Present, and Future: A Chemical Perspective. Pharmacol. Ther. 1998, 77, 29-58.
7. Egan, T. J. Structure-Function Relationships in Chloroquine and Related 4-Aminoquinoline Antimalarials. Mini Rev. Med. Chem. 2001, 1, 113-123.
8. Rieckmann, K. Determination of the Drug Sensitivity of Plasmodium falciparum. JAMA J. Am. Med. Assoc. 1971, 277, 573-578.
9. Chou, A. C.; Fitch, C. D. Control of Heme Polymerase by Chloroquine and other Quinoline Derivatives. Biochem. Biophys. Res. Commun. 1993, 195, 422-427.
10. Slater, A. F. G.; Chloroquine: Mechanism of Drug Action and Resistance in Plasmodium falciparum. Pharmacol. Ther. 1993, 57, 203-235.
11. Hatton, C. S. R.; Bunch, C.; Peto, T. E. A.; Pasvol, G.; Russell, S. J.; Singer, C. R. J.; Edwards, G.; Winstanley, P. Frequency of Severe Neutropenia associated with Amodiaquine Prophylaxis against Malaria. Lancet 1986, 411-414.
12. Neftel, K. A.; Woodtly, W.; Schmid, M.; Frick, P. G.; Fehr, J. Amodiaquine Induces Agranulocytosis and Liver Damage. Br. Med. J. 1986, 292, 721-723.
13. Maggs, J. L.; Kitteringham, N. R.; Park, B. K. Drug-Protein Conjugates. Mechanism of Formation of Protein Arylating Intermediates from Amodiaquine in Man. Biochem. Pharmacol. 1988, 37, 303-311.
14. Harrison, A. C.; Kitteringham, N. R.; Clarke, J. B.; Park, B. K. Mechanism of Bioactivation and Antigene Formation of Amodiaquine in the Rat. Biochem. Pharmacol. 1992, 43, 1421-1430.
15. Delarue, S.; Girault, S.; Maes, L.; Debreu-Fontaine, M.; Labaeid, M.; Grellier, P.; Sergheraert, C. Synthesis and in Vitro and in Vivo Antimalarial Activity of New 4-Aminoquinolines. J. Med. Chem. 2001, 44, 2827-2833.
16. Basak, S. C.; Harriss, D. K.; Magnuson, V. R. POLLY, University of Minnesota: Duluth, MN, 1988.
17. Molconn-Z, ver. 2.07, eduSoft Lc, a Virginia Corporation, Ashland, VA 23005 U.S.A. www.edusoft-lc.com.
18. (a) Katritzky, A. R.; Lobnov, V.; Karelson, M. CODESSA (Comprehensive Descriptors for Structural and Statistical Analysis); University of Florida: Gainesville, FL, 1994.
19. (b) Katritzky, A. R.; Perumal, S.; Petrukhin, R.; Kleinpeter, E. CODESSA-Based Theoretical QSPR Model for Hydantoin HPLC-RT Lipophilicities. J. Chem. Inf. Comput. Sci. 2001, 41, 569-574.
20. DRAGON software version 3.0-2003. By Todeschini, R.; Consonni, V.; Mauri, A.; Pavan, M. Milano, Italy, http://disat.unimib.it/chm/Dragon.htm.
21. Gonzalez, M. P.; Helguera, A. M. TOPS-MODE verces DRAGON Descriptors to Predict Permeability Coefficients through Low-Density Polymer. J. Comput.-Aided Mol. Des. 2003, 17, 665-672.
22. Rogers, D.; Hopfinger, A. J. Application of Genetic Function Approximation to Quantitative Structure Activity Relationship and Quantitative Structure Property Relationship. J. Chem. Inf. Comput. Sci. 1994, 34, 854-866.
23. Kubinyi, H. Variable Selection in QSAR Studies. I. An Evolutionary Algorithm. Quant. Struct.-Act. Relat. 1994, 13, 285-294.
24. Prabhakar, Y. S. A Combinatorial Approach to the Variable Selection in Multiple Linear Regression Analysis of Selwood et al. data set- A Case Study. QSAR Comb. Sci. 2003, 22, 583-595.
25. Prabhakar, Y. S.; Solomon, V. R.; Rawal, R. K.; Gupta, M. K.; Katti, S. B. CP-MLR /PLS Directed Structure-Activity Modeling of the HIV-1 RT Inhibitory Activity of 2,3-Diaryl-1,3-Thiazolidin-4-Ones. QSAR Comb. Sci. 2004, 23, 234-244.
26. Prabhakar, Y. S. A Combinatorial Protocol in Multiple Linear Regression to Model Gas Chromatographic Response Factor of Organophosphonate Esters. Internet Electron. J. Mol. Des. 2004, 3, 150-162. http://www.biochempress.com.
27. Gupta, M. K.; Sagar, R.; Shaw, A. K.; Prabhakar, Y. S. CP-MLR Directed QSAR Studies on the Antimycobacterial Activity of Functionalised Alkenols -Topological Descriptors in Modeling the Activity. Bioorg. Med. Chem. 2005, 13, 343-351.
28. ChemDraw Ultra 6.0 and ChemBats3D Ultra, Cambridge Soft Corporation, Cambridge, U.S.A.
29. The complete data set of independent and dependent descriptors will be provided on request.
30. So, S. S.; Karplus, M. Three-Dimensional Quantitative Structure-Activity Relationship from Molecular Similarity Matrices and Genetic Neural Networks. I. Method and Validations. J. Med. Chem. 1997, 40, 4347-4359.
31. (a) MOE: The Molecular Operating Environment from Chemical Computing Group Inc.. 1255 University Street, Suite 1600, Montreal. Quebec, Canada H3B 3X3.
32. (b) Brown, R. D.: Martin, Y. C. Use of Structure-Activity Data to Compare Structure-Based Clustering. Methods and Descriptors for Use in Compound Selection. J. Chem. Inf. Comput. Sci. 1996, 36, 572-584.
33. SYSTAT, Version 7.0: SPSS Inc., 444 North Michigan Avenue, Chicago, IL 60611.